Retrospective approach to methylenetetrahydrofolate reductase mutations in children.
 
Yazarlar (5)
Prof. Dr. Işıl ÖZER T.C. Saglik Bakanligi Istanbul Goztepe Egitim ve Arastirma Hastanesi, Türkiye
Mustafa Özetin
Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Dr. Öğr. Üyesi Hatice Karaer Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Semiha G. Kurt
Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Emsettin Ahin
Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Makale Türü Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı Pediatric Neurology (Q2)
Dergi ISSN 0887-8994 Dergi Bilgileri (2011)
Dergi Tarandığı Indeksler SSCI
Makale Dili Türkçe Basım Tarihi 07-2011
Cilt / Sayı / Sayfa 45 / 1 / 34–38 DOI 10.1016/j.pediatrneurol.2011.01.019
UAK Araştırma Alanları
Çocuk Metabolizma Hastalıkları (Çocuk Sağlığı ve Hastalıkları)
Özet
Methylenetetrahydrofolate reductase reduces methyltetrahydrofolate, a cosubstrate in the remethylation of homocysteine, from methylenetetrahydrofolate. Congenital defects, hematologic tumors, and intrauterine growth retardation can occur during childhood. This study evaluated clinical and laboratory treatment approaches in children diagnosed with methylenetetrahydrofolate reductase mutations. Our group included 23 boys and 14 girls, aged 103.4 ± 70.8 months S.D. Clinical findings of patients and homocysteine, vitamin B12, folate, hemogram, electroencephalography, cranial magnetic resonance imaging, and echocardiography data were evaluated in terms of treatment approach. Our patients’ findings included vitamin B12 at 400.4 ± 224.6 pg/mL S.D. (normal range, 300-700 pg/mL), folate at 10.1 ± 4.5 ng/mL S.D. (normal range, 1.8-9 ng/mL), and homocysteine at 8.4 ± 4.7 μmol/L S.D. (normal range, 5.5-17 …
Anahtar Kelimeler
Science Direct
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları
Scopus 5
Google Scholar 16
Retrospective approach to methylenetetrahydrofolate reductase mutations in children.

Paylaş